NASDAQ
Investment strategist Shay Boloor has outlined ten sub-$10 billion market-cap companies he believes are positioned to benefit from powerful long-term trends heading into 2026....
TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook....
TransMedics Group's revolutionary organ care system is driving its strong results. Abivax is a David among Goliaths, and its growth story might just be getting started....
Director Edward Basile executed an exercise of 4,142 options with immediate sale of all resulting shares in TransMedics Group (TMDX +0.07%) on October 29, 2025, as disclosed in the SEC Form 4 filing....
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
MercadoLibre has tremendous potential in the Latin American e-commerce and fintech markets. TransMedics Group is preparing to expand into Italy and has plenty of room to grow in the U.S. as well....
Creative Planning boosted its holdings in TransMedics Group, Inc. (NASDAQ: TMDX) by 60.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. Th...
As contradictory as it may sound, my most financially painful transaction has been one of my best investing lessons. These lessons apply to many stocks that I hold, but one in particular stands out to...
TransMedics (TMDX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TMDX broke through the 50-day moving average, which suggests a sh...
From a technical perspective, TransMedics (TMDX) is looking like an interesting pick, as it just reached a key level of support. TMDX recently overtook the 20-day moving average, and this suggests a s...
No price data available for this timeframe.